IRON DEFICIENCY AND ANEMIA IN HEART FAILURE

Öz

Heart failure is an international health problem with its high incidence, prevalence, morbidity and mortality rates. There are many complications that can be seen in patients with heart failure due to pathophysiology, drug side effects, comorbid comorbid diseases and limitations caused by heart failure. Comorbid conditions adversely affect the clinical course, worsen the prognosis, make treatment difficult, and make the clinical picture difficult to control. One of the most common comorbid conditions in heart failure is iron deficiency and anemia. It is important that healthcare professionals, be attentive to iron deficiency and anemia, and raise awareness among patients and their caregivers. In this article, the importance of iron deficiency and anemia, which are common in heart failure patients, will be discussed.

Anahtar Kelimeler

• Anemia
• Iron Deficiency
• Heart Failure

Proje Numarası

Bulunmamaktadır

Kaynakça

1. Jessup, M., Abraham, W., Casey, D., et al.. ACC/AHA Guidelines for the diagnosis and management of heart failure in adults. JACC 2009; 53: 1347-69
2. Çavuşoğlu, Y., Altay, H., Çetiner, M., Güvenç, T. S., Temizhan, A., Ural, D., Yeşilbursa, D., Yıldırım, N., Yılmaz, M. B. Kalp yetersizliğinde demir eksikliği ve anemi. Turk Kardiyol Dern Ars 2017; Suppl 2: 1-38 doi: 10.5543/tkda.2017.79584
3. European Society of Cardiology. European Guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal. 2016, 37, 2315-2381.
4. Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., et al.. (2016). 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur Heart J 2016;37:2129–200
5. Heckman, G. A., Boscart, V. M., D'Elia, T., Lelley, M. L., Kaasalainen, S., McAiney, C. A., et al.. Managing heart failure in long-term care: recommendations from an ınter professional stake holder consultation. Canadian Journal on Aging 2016;35(4):447-467 https://doi.org/10.1017/S071498081600043X
6. Değertekin, M., Erol, Ç., Ergene, O., Tokgözoğlu, L., Aksoy, M., Erol, M. K., et al.. Türkiye’deki kalp yetersizliği prevelansı öngördücüleri: HAPPY çalışması. Türk Kardiyol Dern Arş 2012;40(4):298-308. http://dx.doi.org/10.5543/tkda.2012.65031
7. Abraham, W.T., Krum, H. (2007). Kalp Yetersizliği Tedaviye Pratik Bir Yaklaşım. 1. Baskı. İstanbul: Cordis Group
8. Jankowska, E. A., Tkaczyszyn, M., Suchocki, T., Drozd, M., Von Haehling, S., Doehner, W., et al. Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: meta-analysis of randomized controlled trials. Eur J Heart Fail 2016;18:786–95

9. Tokgözoğlu, L., Yılmaz, M. B., Abacı, A., Altay, H., Atalar, E., et al. Türkiye’de kalp yetersizliği yol haritası kalp yetersizliğinin ve buna bağlı ölümlerin önlenmesi amacıyla geliştirilebilecek politikalara ilişkin öneriler. TKD, 2015; 1-31
10. Westenbrink, B. D., Alings, M., Granger, C. B., Alexander, J. H., Lopes, R. D., Hylek, E. M., et al. Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: In¬sights from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial. Am Heart J 2017;185:140–9
11. Silverberg DS, Wexler D, Blum M et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function, functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol. 2000; 35:1737-1744
12. Argan O, Özgün Ö, Bozyel S, Ural D, Kozdag G, Ağır A.A, et al. Pulmonary Artery Systolic Pressure and Right Sided Heart Failure Symptoms: a Predictor for Progression of Iron Deficiency to Iron Deficiency Anemia in Heart Failure Patients. Kocaeli Med J. 2020;9; 1:68-75
13. Tang WH, Yeo PSD. Epidemiology of anemia in heart failure. Heart Failure Clin. 2010;6:271–8
14. Sarı, İ., Çavuşoğlu, Y., Temizhan, A., Yılmaz, M. B., Eren, M. 2016 ESC and ACC/AHA/HFSA Heart failure guideline updates: changes similarities, differences, and unresolved isssues. Turk Kardiyol Dern Ars 2016;44(8):625-636.
15. Dunn, L. L., Suryo, Rahmanto, Y., Richardson, D. R. Iron uptake and metabolism in the new millennium. Trends Cell Biol 2007;17:93–100
16. Nemeth, E. Iron regulation and erythropoiesis. Curr Opin He¬matol 2008;15:169–75
17. Suchdev, P. S., Williams, A. M., Mei, Z., Flores-Ayala, R., Pasricha, S. R., Rogers, L. M., et al. Assessment of iron status in settings of inflammation: challenges and potential approaches. Am J Clin Nutr 2017;106:1626S–33
18. Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., et al. ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016;37:2893–962
19. Büyüklü M. Kalp yetersizliği: Anemi Tedavisinde Eritropoetin. Anadolu Kardiyoloji Dergisi. 2007;7(3).
20. Metivier F, Marchais SJ, Guerin AP, Pannier B, London GM. Pathophysiology of anaemia: focus on the heart and blood vessels. Nephrol Dial Transpl. 2000;15(3):14-8.
21. Wu WC, Rathore S, Wabg Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med. 2001;345(17):1230-6.
22. Okonko, D., Mandal, A., Missouris, C., Poole-Wilson, P. Disorderediron homeostasis in chronic heart failure. J Am Coll Cardiol 2011;58:1241–51
23. Kişioğlu AN, Uskun, E., Kırbıyık S., Uzun, E., Polat, M., Canatan, D. Bir Dağlık Bölge Sakinlerinde Anemi Çalışması: Kekik İşçileri. STED 2004,13(7):252-257
24. Wong, C. C. Y., Ng, A. C. C., Kritharides, L., Sindone, A. P. Iron deficiency in heart failure: looking beyond anemia. Heart, Lung and Circulation 2016;25:209–16
25. Jankowska, E. A., Rozentryt, P., Witkowska, A., Nowak, J., Hartmann, O., Ponikowska, B., et al. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J 2010;31:1872–80
26. Anand, I. S., Kuskowski, M. A., Rector, T. S., et al. Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from val-heft. Circulation 2005;112:1121–7
27. Horwich, T. B., Fonarow, G. C., Hamilton, M. A., MacLellan, W. R., Borenstein, J. Anemia iassociated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002;39:1780–6
28. Silverberg, D. S., Wexler, D., Palazzuoli, A., Laina, A., Schwartz, D. The anemia of heart failure. Acta Haematol 2009;122:109–19
29. Özcan Örsçelik Ö., Özkan B. Mersin Üniversitesi Kardiyoloji Kliniğinde Kalp Yetersizliği ile Takip Edilen Hastalarda Anemi Sıklığı: Pilot Çalışma. Lokman Hekim Dergisi, 2018; 8 (3):212-217.
30. Brucks, S., Little, W. C., Chao, T., Rideman, R. L., Upadhya, B., Wesley Farrington, D., et al. Relation of anemia to diastolic heart failure and the effect on outcome. Am J Cardiol 2004;93:1055–7
31. Tehrani, F., Phan, A., Morrissey, R., Chien, C., Rafique, A., Schwarz, E. R. The prognostic value of anemia in patients with diastolic heart failure. Tex Heart Inst J 2009;36:220–5
32. Dunlay, S. M., Weston, S. A., Redfield, M. M., Killian, J. M., Roger, V. L. Anemia and heart failure: a community study. Am J Med 2008;121:726–32
33. Caughey, M. C., Avery, C. L., Ni, H., Solomon, S. D., Matsushita, K., Wruck, L. M., et al. Outcomes of patients with anemia and acute decompensated heart failure with preserved versus reduced ejection fraction (from the ARIC study community surveillance). Am J Cardiol 2014;114:1850–4
34. Kasner, M., Aleksandrov, A. S., Westermann, D., Lassner, D., Gross, M., von Haehling, S., et al. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction. Int J Cardiol 2013;168:4652–7
35. Núñez, J., Domínguez, E., Ramón, J. M., Núñez, E., Sanchis, J., Santas, E., et al. Iron deficiency and functional capacity in patients with advanced heart failure with preserved ejection fraction. Int J Cardiol.2016; 207:365–7
36. Parikh, A., Natarajan, S., Lipsitz, S. R., Katz, S. D. Iron deficiency in community-dwelling US adults with self-reported heart failure in the national health and nutrition examination survey III: prevalence and associations with anemia and inflammation. Circ Heart Fail, 2011;4:599–606
37. Klip, I., Comin-Colet, J., Voors, A., Ponikowski, P., Enjuanes, C., Banasiak, W., et al.. Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J. 2013;165:575–82
38. Doğan, S. (2013). Kronik kalp yetersizliğinde görülen anemide hepsidin molekülünün rolü ve eritrosit dağılım genişliği artışı ile ilişkisi. Yayınlanmamış uzmanlık tezi. Uludağ Üniversitesi Tıp Fakültesi.
39. Canım Y., Eralp B., Bambul N., Akyer, E, Çiftçi H. Kronik kalp yetersizliği ve anemisi olan hastalarda intravenöz demir tedavisinin egzersiz kapasitesi ve kardiyak fonksiyonlara etkisi. Göztepe Tıp Dergisi. 2009; 24(3):125-128
40. Konak, Ş., Polat M. Glukoz 6 Fosfat Dehidrogenaz Enzim Eksikliği; Tanı ve Tedavi MAKÜ Sag. Bil. Enst. Derg. 2015, 3(2): 77-83.
41. Anker, S. D., Comin Colet, J., Filippatos, G., Willenheimer, R., Dickstein, K., Drexler, H., et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361:2436–48
42. Lipschitz D. Medical and functional consequences of anemia in the elderly. J Am Geriatr Soc.2003;51(3 Suppl):10-3
43. Kılıçgedik A, Dündar C, Tigen M.K. Anemia in heart failure. Anadolu Kardiyoloji Dergisi.2012; 12: 65-70